FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.

While many Canadian stocks are trading at 52-week highs, these two top TSX stocks are undervalued, making them among the best ...

McLaren does not have a nominated reserve but its relationship with Mercedes means it has had its reserve drivers as back-ups ...

If you need to generate income from your investments, selecting securities or funds based on their current interest or dividend payouts might solve the immediate problem. But a strategy of increasing ...

For example, the recent F share price of $9.24 represents a price-to-book ratio of 0.8 and an annual dividend yield of 6.49% ...

The stock looks like a decent value, but it could be a bargain if management can execute. Its dividend checks all the boxes ...

Dividend growth investing is a proven, low-risk strategy for building wealth. Check out my four dividend growth stock picks ...

The company's announcement that it was walking back its 2028 goals for smoke-free products warranted a closer look at its ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Star Group continues to outperform with volume gains and solid earnings. See why SGU stock’s 12.16% return projection makes ...

Key Insights Using the Dividend Discount Model, SJW Group fair value estimate is US$54.89 SJW Group's US$50.82 ...

Clorox (NYSE:CLX – Free Report) had its price target hoisted by Barclays from $130.00 to $140.00 in a research note issued to ...